Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Study: Deal terms getting richer as pharmas stockpile antibody tech
Study: Deal terms getting richer as pharmas stockpile antibody tech
Study: Deal terms getting richer as pharmas stockpile antibody tech
Submitted by
admin
on November 8, 2011 - 11:06am
Source:
Fierce Biotech
News Tags:
antibodies
autoimmune disease
CNS
Roche
AstraZeneca
Bristol-Myers Squibb
Novartis
Pfizer
Merck
mAb
Headline:
Study: Deal terms getting richer as pharmas stockpile antibody tech
Do Not Allow Advertisers to Use My Personal information
